A detailed history of Cordatus Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cordatus Wealth Management LLC holds 4,109 shares of LLY stock, worth $3.27 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
4,109
Previous 4,503 8.75%
Holding current value
$3.27 Million
Previous $4.08 Million 10.72%
% of portfolio
1.31%
Previous 1.53%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $304,223 - $378,247
-394 Reduced 8.75%
4,109 $3.64 Million
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $3.26 Million - $4.09 Million
4,503 New
4,503 $4.08 Million
Q2 2023

Jul 14, 2023

BUY
$350.74 - $468.98 $319,874 - $427,709
912 New
912 $428,000
Q3 2022

Oct 25, 2022

SELL
$296.48 - $337.87 $296 - $337
-1 Reduced 0.02%
4,175 $1.35 Million
Q2 2022

Aug 24, 2022

BUY
$278.73 - $327.27 $909,774 - $1.07 Million
3,264 Added 357.89%
4,176 $1.35 Million
Q1 2022

May 06, 2022

SELL
$234.69 - $291.66 $21,356 - $26,541
-91 Reduced 9.07%
912 $261,000
Q4 2021

Feb 08, 2022

BUY
$224.85 - $279.04 $225,524 - $279,877
1,003 New
1,003 $277,000
Q3 2020

Oct 23, 2020

SELL
$146.22 - $169.13 $3.2 Million - $3.7 Million
-21,867 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$136.42 - $164.18 $1.12 Million - $1.35 Million
-8,224 Reduced 27.33%
21,867 $3.59 Million
Q1 2020

Apr 21, 2020

BUY
$119.05 - $147.35 $3.58 Million - $4.43 Million
30,091 New
30,091 $4.17 Million
Q2 2019

Jul 29, 2019

SELL
$110.79 - $129.32 $6.44 Million - $7.51 Million
-58,103 Closed
0 $0
Q1 2019

May 07, 2019

SELL
$111.31 - $131.02 $2.07 Million - $2.44 Million
-18,634 Reduced 24.28%
58,103 $7.54 Million
Q4 2018

Jan 31, 2019

BUY
$105.9 - $118.64 $8.13 Million - $9.1 Million
76,737 New
76,737 $8.88 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cordatus Wealth Management LLC Portfolio

Follow Cordatus Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cordatus Wealth Management LLC with notifications on news.